{"name":"Alcobra Ltd.","slug":"alcobra-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":15753000,"revenueGrowth":21.2,"grossMargin":0,"rdSpend":16982000,"netIncome":-21785000,"cash":44198000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Metadoxine extended release","genericName":"Metadoxine extended release","slug":"metadoxine-extended-release","indication":"Acute alcohol intoxication","status":"marketed"}]}],"pipeline":[{"name":"Metadoxine extended release","genericName":"Metadoxine extended release","slug":"metadoxine-extended-release","phase":"marketed","mechanism":"Metadoxine is a combination of pyridoxine (vitamin B6) and L-2-aminoethanol that enhances acetaldehyde metabolism and reduces its toxic accumulation in alcohol-related disorders.","indications":["Acute alcohol intoxication","Alcohol-related liver disease","Hangover symptoms"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQQjRITlJBRHZ5dVFnckxOei1uUFJSTWh0bDVDQlZuSlRtZ20zOFhCaGVXWHV4OEVVWlVhM1FZWEpWc2NaWXNzSTBwNkx3SG4wdUhYMXdlVlBqTk5PRmcteDF5RjZXOE9JQWFCTjZRekdBMHFMRlBCQ0I3UzI3LTE3dHR3VGxMTm5LN05vbmZWVk5KWG0wcDhMQTZ2OFpaVjVhMHBQWXVrc2tzVGQ3SXU1YV9R?oc=5","date":"2025-08-05","type":"deal","source":"Pharmaceutical Online","summary":"Bristol Myers Squibb Forms Immunology Company With Finance Partner - Pharmaceutical Online","headline":"Bristol Myers Squibb Forms Immunology Company With Finance Partner","sentiment":"neutral"},{"date":"2019-08-01","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"date":"2019-06-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2019-05-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2019-05-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2019-05-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2019-03-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: ARCT 8-K - Q4 2018 PR","headline":"SEC 8-K: ARCT 8-K - Q4 2018 PR","sentiment":"neutral"},{"date":"2019-03-18","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPUWcwMlVNb2piZlRxNjdULWNicUdHZ211NVVrdXlzVTh6WHpibkhzRGQtWEF2NWp3WGd5RE5qNGlmdDVGLXh5el9HZVVlUmhYbld1NWZsdGYzTmpELTlReWE0blgtVC1vamVfM0xwMFJlR3FkQ280NE81T0tWcWVpeHJWbzlJM0pxbzFRR29hYmYzU0E?oc=5","date":"2018-11-25","type":"pipeline","source":"Globes - Israel Business News","summary":"Teva's loss is Israeli pharma industry's gain - Globes - Israel Business News","headline":"Teva's loss is Israeli pharma industry's gain - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNb2JDVjM2M2ZMSllnbTRqdjJqSERIQ3hnRW4wYmgwX3hfS1NwZDVSUVhUcjlfTUlqV3E2WVRJWjllbV9tUGMzY080bHIyeXM2b2o1akowejFJOUJKanRkVDE1NXhsODZpelg5WUdneEhnUlBMOElKeUtuNGsyRG9hOExNbUVOQjVDVzhoRTNta2xmUjJ1UV9aOExLWFJnY28?oc=5","date":"2017-11-09","type":"pipeline","source":"Globes - Israel Business News","summary":"Israel's Nextar setting up medical cannabis incubator - Globes - Israel Business News","headline":"Israel's Nextar setting up medical cannabis incubator - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNT2c3RGpyZUpQeExob05RcEVQcjFSaDRWeG92VTd6YlUta0Z1ZmhuSFJaWGlJTEIteEpHbVpNWEo1U2dMWE9nUzVtRnpYR2lNQzd6X2dKNmhqOUlPUDYtWnJYY0h0OWZhQTMzMG01LWp5QnVFRW5CWGNnUEg1eWdTQWtKYk9JY2E4Z0FuVWI1ZnBjdV9r?oc=5","date":"2017-10-20","type":"deal","source":"BioPharma Dive","summary":"Arcturus expands partnership with J&J into hepatitis B - BioPharma Dive","headline":"Arcturus expands partnership with J&J into hepatitis B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPcHRjSUFfRU5VOWh0ZXNqQXBaaTlyRml4NEFUYXFVNWRRZVRmWjR6LVlGMmp5ZjZRWGtxQl9MdEN4SFYwVUxqUHlHZEdyU2hyTWxKc2V2ZU5DUFlEUGduSFl0OXBuSEtBeDFlckw0SFNVVXdXemwyRFFfVDJYdkNmWWFiRVhtdTNxNzB3azQ0emt6bzlLc1RZ?oc=5","date":"2017-09-29","type":"deal","source":"BioPharma Dive","summary":"Arcturus to go public through merger with Alcobra - BioPharma Dive","headline":"Arcturus to go public through merger with Alcobra","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":15753000,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":15753000,"period":"2018-12-31"},{"value":12998000,"period":"2017-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":16982000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-21785000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":44198000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}